BENTONVILLE, Ark., Oct. 3, 2012 /PRNewswire/ -- Over the course of a lifetime, 1 in 8 women will be diagnosed with breast cancer, making it one of the leading causes of cancer deaths among women. In support of Women's Health...
NASHVILLE, Tenn., Oct. 3, 2012 /PRNewswire/ -- Healthcare Realty Trust Incorporated (NYSE:HR) announced that members of its management team will participate in REITWorld 2012: NAREIT's Annual Convention for All Things REIT in San Diego, California, November 13–15, 2012. To schedule...
Funds will support local Ys' efforts to ensure opportunities for healthy living are accessible to all WASHINGTON, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Today, YMCA of the USA (Y-USA), the national resource office for the nation's 2,700 YMCAs, was awarded...
BEDFORD, Mass., Oct. 3, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today...
PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented...
HOUSTON, Oct. 3, 2012 /PRNewswire/ -- Kraton Performance Polymers, Inc. (NYSE: KRA), a leading global producer of styrenic block copolymers, announced today that it plans to expand hydrogenated styrenic block copolymer (HSBC) manufacturing capability in Asia on a stand-alone basis. Locations in...
Kronos Early Estrogen Prevention Study results to help clinicians assess HT risk-benefits PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Kronos Longevity Research Institute (KLRI) today announced that a major finding of the Kronos Early Estrogen Prevention Study (KEEPS) indicates that hormone therapy...
GAITHERSBURG, Md., Oct. 3, 2012 /PRNewswire/ -- MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis® (palivizumab) is within the acceptable range of cost effectiveness. Specifically, the study...
NEWTON, Mass., Oct. 3, 2012 /PRNewswire/ -- Kathy Bliss, MSN, RN, CHPCA, has assumed the position of President of the Hospice & Palliative Federation of Massachusetts. Bliss has been a member of the Board of Directors of The Hospice &...
Joins Elite Group of America's Leading Charities WASHINGTON, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) proudly announced that for the third consecutive year, it has received the highest and coveted 4-star rating from Charity Navigator, the nation's...
